醛固酮生成失调的谱系:一项国际人类生理学研究
该国际多中心人类生理学研究纳入348例低肾素表型受试者,覆盖正常血压至严重/难治性高血压。盐水抑制试验显示非抑制性、非肾素依赖性醛固酮生成呈连续谱,与血压连续谱平行;ACTH介导的醛固酮生成也呈连续谱,且与ACTH刺激后醛固酮强相关(r=0.75,P<.0001)。在未达原发性醛固酮增多症诊断阈值者中,15%仍存在可手术的侧化性醛固酮增多症。
要点
- 低肾素表型者中非抑制性、非肾素依赖性醛固酮生成呈连续谱,与血压水平平行。
- ACTH介导的醛固酮生成亦呈连续谱,与ACTH刺激后醛固酮强相关(r=0.75,P<.0001)。
- 未达诊断阈值者中15%仍存在侧化性醛固酮增多症,可考虑手术或MR拮抗剂治疗。
核心结论
- 在低肾素表型背景下,原发性醛固酮增多症和醛固酮生成失调呈连续谱,且受ACTH显著影响。
- 相当比例的低肾素个体可能从醛固酮靶向治疗中获益。
研究设计与样本
- 国际4中心人类生理学研究,纳入348例低肾素表型受试者,涵盖严重和/或难治性高血压、高血压伴低钾血症、血压升高及I/II期高血压和正常血压。
- 采用盐水抑制试验量化非肾素依赖性醛固酮生成,地塞米松抑制和ACTH刺激试验量化ACTH介导的醛固酮生成,肾上腺静脉采血判断侧化。
主要发现
- 盐水抑制试验后非抑制性和非肾素依赖性醛固酮生成呈连续谱,与血压连续谱平行并超越传统诊断阈值。
- ACTH介导的醛固酮生成呈连续谱,盐水抑制试验后醛固酮与ACTH刺激后醛固酮强相关(r=0.75,P<.0001),与地塞米松抑制后非抑制性醛固酮相关(r=0.40,P<.0001)。
- 在符合原发性醛固酮增多症标准(盐水抑制试验后醛固酮≥10 ng/dL或≥277 pmol/L)者之外,非抑制性和非肾素依赖性醛固酮生成连续谱持续存在于该诊断阈值以下,其中15%仍存在可手术肾上腺切除术的侧化性醛固酮增多症,其余接受盐皮质激素受体拮抗剂治疗。
关键数值与推荐
- 原发性醛固酮增多症诊断标准:盐水抑制试验后醛固酮≥10 ng/dL或≥277 pmol/L。
- 盐水抑制试验后醛固酮与ACTH刺激后醛固酮相关(r=0.75,P<.0001),与地塞米松抑制后非抑制性醛固酮相关(r=0.40,P<.0001)。
- 未达诊断阈值者中15%存在侧化性醛固酮增多症,可手术肾上腺切除术,其余接受盐皮质激素受体拮抗剂治疗。
临床怎么用
- 在低肾素表型个体中,应关注醛固酮生成失调的连续谱,而非仅依赖传统诊断阈值。
- 对未达原发性醛固酮增多症诊断阈值者,仍需评估侧化性醛固酮增多症的可能性,15%可考虑手术。
- ACTH介导的醛固酮生成在低肾素表型中占重要地位,可能影响治疗选择。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Primary aldosteronism is a form of low-renin hypertension characterized by dysregulated aldosterone production. OBJECTIVE: To investigate the contributions of renin-independent aldosteronism and ACTH-mediated aldosteronism in individuals with a low-renin phenotype representing the entire continuum of blood pressure. DESIGN/PARTICIPANTS: Human physiology study of 348 participants with a low-renin phenotype with severe and/or resistant hypertension, hypertension with hypokalemia, elevated blood pressure and stage I/II hypertension, and normal blood pressure. SETTING: 4 international centers. INTERVENTIONS/MAIN OUTCOME MEASURES: The saline suppression test (SST) to quantify the magnitude of renin-independent aldosteronism; dexamethasone suppression and ACTH-stimulation tests to quantify the magnitude of ACTH-mediated aldosteronism; adrenal venous sampling to determine lateralization. RESULTS: There was a continuum of nonsuppressible and renin-independent aldosterone production following SST that paralleled the magnitude of the blood pressure continuum and transcended conventional diagnostic thresholds. In parallel, there was a full continuum of ACTH-mediated aldosteronism wherein post-SST aldosterone levels were strongly correlated with ACTH-stimulated aldosterone production (r = 0.75, P < .0001) and nonsuppressible aldosterone production postdexamethasone (r = 0.40, P < .0001). Beyond participants who met the criteria for primary aldosteronism (post-SST aldosterone of ≥10 ng/dL or ≥277 pmol/L), the continuum of nonsuppressible and renin-independent aldosterone production persisted below this diagnostic threshold, wherein 15% still had lateralizing aldosteronism amenable to surgical adrenalectomy and the remainder were treated with mineralocorticoid receptor antagonists. CONCLUSION: In the context of a low-renin phenotype, there is a continuum of primary aldosteronism and dysregulated aldosterone production that is prominently influenced by ACTH. A large proportion of individuals with low renin may benefit from aldosterone-directed therapy.
引用
- Parksook WW, Brown JM, Omata K, et al. The Spectrum of Dysregulated Aldosterone Production: An International Human Physiology Study. J Clin Endocrinol Metab. 2024. PMID: 38450549. doi:10.1210/clinem/dgae145
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。